Gall bladder mucocoele is the most common indication for gall bladder surgery in dogs. It develops when there is hypersecretion of abnormally thick mucus from the gall bladder epithelim. This gelatinous material accumulates, progressively filling the lumen and often extending into bile ducts. The result can be extrahepatic biliary obstruction, thinning of the gall bladder wall, secondary bacterial infection, or gall bladder rupture with bile peritonitis.
Over-represented breeds include Shetland Sheepdogs, Border Terriers, Miniature Schnauzers, Cocker Spaniels and Pomeranians. The condition predominantly affects older, small-to-medium purebred dogs (median age around 10 years), with no clear sex predilection. The precise aetiopathogenesis remains incompletely defined, but key predisposing factors include gall bladder hypomotility, cholestasis, genetic influences (including ABCB4 mutations in some lines), hyperlipidaemia, and concurrent endocrinopathies—particularly hyperadrenocorticism and hypothyroidism. Hypercholesterolaemia, hypertriglyceridaemia and proteinuria are also frequently identified.
Clinical signs are often vague and non-specific: lethargy, hyporexia or anorexia, vomiting, diarrhoea, abdominal pain and jaundice. Most cases are discovered incidentally during abdominal ultrasound performed for other reasons. Blood test abnormalities commonly include elevated ALP, ALT, AST and bilirubin, together with an inflammatory leukogram. Abdominal ultrasound remains the cornerstone of diagnosis. Mature mucocoeles classically display a stellate or finely striated, non-gravity-dependent pattern classically likened to a “kiwi fruit.” Earlier or less advanced lesions may show adherent, immobile mucus without the full stellate appearance. Ultrasound is also useful for assessing wall integrity and free abdominal fluid, although sensitivity for rupture is imperfect.
The shift toward proactive surgery
Historically, many clinicians adopted a “wait-and-see” approach—medical management with ursodeoxycholic acid, SAMe, dietary fat restriction and treatment of concurrent endocrinopathies, reserving surgery for dogs that became systemically unwell or showed progressive ultrasonographic change. Current evidence and expert consensus increasingly support a more proactive stance.
Elective cholecystectomy performed while the patient is clinically stable and the mucocoele is still incidental carries a markedly lower short-term mortality (approximately 5–6 %) than nonelective surgery once clinical signs, hyperbilirubinaemia, duct obstruction or rupture have developed (17–23 % or higher). Rupture itself increases the odds of death roughly 2.7-fold. Overall historical mortality figures of 20–39 % largely reflect the higher-risk population operated after complications have already occurred. Dogs that survive the immediate perioperative period enjoy an excellent long-term prognosis.
These data have driven a clear shift in thinking: early removal while the patient is stable is preferable to prolonged medical monitoring of a mature mucocoele. Medical therapy may still have a role in carefully selected early or “pre-mucocele” cases under close ultrasonographic surveillance, or when surgery is declined or contraindicated, but it is no longer regarded as the default first-line strategy for established lesions.
This evolving consensus was reinforced at the recent AVA Science Week conference on the Gold Coast, where Dr Bryden Stanley reviewed current management options and advocated early surgical intervention. Dr James Simcock attended that session and shares the view that proactive cholecystectomy offers the best balance of safety and outcome for most dogs.
Minimally invasive options at Southpaws
At Southpaws we routinely perform both open and laparoscopic cholecystectomy. In carefully selected cases—stable patients without evidence of rupture, significant duct obstruction or extensive adhesions—laparoscopic (“key-hole”) cholecystectomy is an excellent option. The benefits are those familiar from other minimally invasive procedures: reduced post-operative pain, lower surgical-site infection risk, faster return to normal activity and shorter hospitalisation. Our surgical team has the equipment and experience to offer this advanced approach when appropriate, while retaining the ability to convert to open surgery if needed.
Concurrent liver biopsy and aerobic/anaerobic bile culture are standard. Screening for and management of concurrent hypothyroidism, hyperadrenocorticism and hyperlipidaemia remain essential both peri-operatively and long-term.
Practical take-aways for referring clinicians
- Consider abdominal ultrasound early in any older small-breed dog presenting with non-specific gastrointestinal signs or elevated liver enzymes.
- An incidental or early mucocoele is not necessarily an indication for prolonged medical management—discuss elective cholecystectomy while the patient is still well.
- Prompt referral of both symptomatic and asymptomatic cases allows optimal timing of surgery and access to minimally invasive options where suitable.
- Early intervention meaningfully reduces the risk of rupture, sepsis and death.
Gall bladder mucocoele is a progressive, potentially life-threatening condition whose prognosis is dramatically improved by timely surgery. We welcome discussion of individual cases and are happy to review imaging or bloodwork to help determine the most appropriate next step for your patients.
